Sana Biotechnology, Inc.
SANA
$4.09
$0.122.90%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -0.54% | -9.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.27% | -9.64% | |||
| Operating Income | -3.27% | 9.64% | |||
| Income Before Tax | 55.06% | -89.92% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 55.06% | -89.92% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 55.06% | -89.92% | |||
| EBIT | -3.27% | 9.64% | |||
| EBITDA | -2.69% | 8.67% | |||
| EPS Basic | 58.87% | -89.23% | |||
| Normalized Basic EPS | 5.78% | 10.08% | |||
| EPS Diluted | 58.87% | -89.23% | |||
| Normalized Diluted EPS | 5.78% | 10.08% | |||
| Average Basic Shares Outstanding | 9.26% | 0.35% | |||
| Average Diluted Shares Outstanding | 9.26% | 0.35% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||